Abstract
Dementia in patients with idiopathic Parkinson’s disease (PD) increases functional impairment both directly, through the limitations imposed by cognitive impairment, and indirectly, due to increased susceptibility to the psychiatric side effects of dopaminergic and anticholinergic therapy, leading to restricted medication use and increased motor impairment. Cognitive impairment in PD has been shown to affect quality of life (1) and contribute to caregiver distress (2), and has been associated with nursing home placement (3). The development of dementia is also associated with reduced survival in patients with PD (4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schrag, A., Jahanshahi, M., and Quinn, N. (2000) What contributes to quality of life in patients with Parkinson’s disease? J. Neurol. Neurosurg. Psychiatry 69, 308–312.
Aarsland, D., Larsen, J.P., Karlsen, K., Lim, N.G., and Tandberg, E. (1999) Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. Int. J. Geriatr. Psychiatry 14, 866–874.
Aarsland, D., Larsen, J.P., Tandberg, E., and Laake, K. (2000) Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J. Am. Geriatr. Soc. 48, 938–942.
Marder, K., Leung, D., Tang, M., et al. (1991) Are demented patients with Parkinson’s disease accurately reflected in prevalence surveys? A survival analysis. Neurology 41, 1240–1243.
Brown, R.G. and Marsden, C.D. (1984) How common is dementia in Parkinson’s disease? Lancet 2, 1262–1265.
Cummings, J.L. (1988) Intellectual impairment in Parkinson’s disease: clinical, pathologic, and biochemical correlates. J. Geriatr. Psychiatry Neurol. 1,24–36.
Dubois, B., Boller, F., Pillon, B., and Agid, Y. (1991) Cognitive deficits in Parkinson’s disease, in Handbook of Neuropsychology (Boller, F. and Grafman, J., eds.), Elsevier Science Publishers, New York, pp. 195–240.
Marder, K. and Mayeux, R. (1991) The epidemiology of dementia in patients with Parkinson’s disease. Adv. Exp. Med. Biol. 295, 439–445.
Hughes, A.J., Daniel, S.E., Kilford, L., and Lees, A.J. (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181–184.
Aarsland, D., Tandberg, E., Larsen, J.P., and Cummings, J.L. (1996) Frequency of dementia in Parkinson disease. Arch. Neurol. 53, 538–542.
Marttila, R.J. and Rinne, U.K. (1976) Dementia in Parkinson’s disease. Acta Neurol. Scand. 54, 431–441.
Winikates, J. and Jankovic, J. (1999) Clinical correlates of vascular parkinsonism. Arch. Neurol. 56, 98–102.
Sroka, H., Elizan, T.S., Yahr, M.D., Burger, A., and Mendoza, M.R. (1981) Organic mental syndrome and confusional states in Parkinson’s disease. Relationship to computerized tomographic signs of cerebral atrophy. Arch. Neurol. 38, 339–342.
Hershey, L.A. (1982) Organic mental syndrome in Parkinson’s disease. Arch. Neurol. 39, 456–457.
Hughes, A.J., Ben Shlomo, Y., Daniel, S.E., and Lees, A.J. (1992) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42, 1142–1146.
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Press, Washington, DC.
Martin, W.E., Loewenson, R.B., Resch, J.A., and Baker, A.B. (1973) Parkinson’s disease. Clinical analysis of 100 patients. Neurology 23, 783–790.
Celesia, G.G. and Wanamaker, W.M. (1972) Psychiatric disturbances in Parkinson’s disease. Dis. Nerv. Syst. 33, 577–583.
Taylor, A., Saint-Cyr, J.A., and Lang, A.E. (1985) Dementia prevalence in Parkinson’s disease. Lancet 1, 1037.
Oyebode, J.R., Barker, W.A., Blessed, G., Dick, D.J., and Britton, P.G. (1986) Cognitive functioning in Parkinson’s disease: in relation to prevalence of dementia and psychiatric diagnosis. Br. J. Psychiatry 149, 720–725.
Helkala, E.L., Laulumaa, V., Soininen, H., and Riekkinen, P.J. (1988) Recall and recognition memory in patients with Alzheimer’s and Parkinson’s diseases. Ann. Neurol. 24, 214–217.
Stern, Y., Tang, M.X., Jacobs, D.M., et al. (1998) Prospective comparative study of the evolution of probable Alzheimer’s disease and Parkinson’s disease dementia. J. Int. Neuropsychol. Soc. 4, 279–284.
Pirozzolo, F.J., Hansch, E.C., Mortimer, J.A., Webster, D.D., and Kuskowski, M.A. (1982) Dementia in Parkinson disease: a neuropsychological analysis. Brain Cogn. 1, 71–83.
Folstein, M.F., Folstein, S.E., and McHugh, P.R. (1975) “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198.
Boyd, J.L., Cruickshank, C.A., Kenn, C.W., et al. (1991) Cognitive impairment and dementia in Parkinson’s disease: a controlled study. Psychol. Med. 21, 911–921.
Mayeux, R., Chen, J., Mirabello, E., et al. (1990) An estimate of the incidence of dementia in idiopathic Parkinson’s disease. Neurology 40, 1513–1517.
Mindham, R.H., Ahmed, S.W., and Clough, C.G. (1982) A controlled study of dementia in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 45, 969–974.
Ebmeier, K.P., Calder, S.A., Crawford, J.R., Stewart, L., Besson, J.A., and Mutch, W.J. (1990) Parkinson’s disease in Aberdeen: survival after 3.5 years. Acta Neurol. Scand. 81, 294–299.
Piccirilli, M., D’Alessandro, P., Finali, G., and Piccinin, G.L. (1994) Neuropsychological follow-up of parkinsonian patients with and without cognitive impairment. Dementia 5, 17–22.
Roos, R.A., Jongen, J.C., and van der Velde, E.A. (1996) Clinical course of patients with idiopathic Parkinson’s disease. Mov. Disord. 11, 236–242.
Louis, E.D., Marder, K., Cote, L., Tang, M., and Mayeux, R. (1997) Mortality from Parkinson disease. Arch. Neurol. 54, 260–264.
Stern, M.B. (1988) The clinical characteristics of Parkinson’s disease and parkinsonian syndromes: diagnosis and assessment, in The Comprehensive Management of Parkinson’s Disease (Stern, M.B. and Murtig, M.I., eds.), PMA Publishing Corp., New York, pp. 3–50.
Biggins, C.A., Boyd, J.L., Harrop, F.M., et al. (1992) A controlled, longitudinal study of dementia in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 55, 566–571.
Marder, K., Tang, M.X., Cote, L., Stern, Y., and Mayeux, R. (1995) The frequency and associated risk factors for dementia in patients with Parkinson’s disease. Arch. Neurol. 52, 695–701.
Mahieux, F., Fenelon, G., Flahault, A., Manifacier, M.J., Michelet, D., and Boller, F. (1998) Neuropsychological prediction of dementia in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 64, 178–183.
Hughes, T.A., Ross, H.F., Musa, S., et al. (2000) A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology 54, 1596–1602.
Aarsland, D., Andersen, K., Larsen, J.P., Lolk, A., Nielsen, H., and Kragh-Sorensen, P. (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56, 730–736.
Breteler, M.M., de Groot, R.R., van Romunde, L.K., and Hofman, A. (1995) Risk of dementia in patients with Parkinson’s disease, epilepsy, and severe head trauma: a register-based follow-up study. Am. J. Epidemiol. 142, 1300–1305.
Rajput, A.H., Offord, K.P., Beard, C.M., and Kurland, L.T. (1987) A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson’s disease. Neurology 37, 226–232.
Mayeux, R., Denaro, J., Hemenegildo, N., et al. (1992) A population-based investigation of Parkinson’s disease with and without dementia. Relationship to age and gender. Arch. Neurol. 49, 492–497.
Stern, Y., Marder, K., Tang, M.X., and Mayeux, R. (1993) Antecedent clinical features associated with dementia in Parkinson’s disease. Neurology 43, 1690–1692.
Hely, M.A., Morris, J.G., Reid, W.G., et al. (1995) Age at onset: the major determinant of outcome in Parkinson’s disease. Acta Neurol. Scand. 92, 455–463.
Guillard, A. and Chastang, C. (1978) Maladie de Parkinson. Les facteurs de pronostic a long terme. Revue Neurologique 134, 341–354.
Marder, K., Flood, P., Cote, L., and Mayeux, R. (1990) A pilot study of risk factors for dementia in Parkinson’s disease. Mov. Disord. 5, 156–161.
Glatt, S.L., Hubble, J.P., Lyons, K., et al. (1996) Risk factors for dementia in Parkinson’s disease: effect of education. Neuroepidemiology 15, 20–25.
Ramakrishnan, R., Zareparsi, S., Gancher, S., Camicioli, R., Nutt, J., and Payami, H. (2001) Risk factors for Parkinson’s dementia: age, male gender, and apolipoprotein e2. Neurology 56, A113.
Diamond, S.G., Markham, C.H., Hoehn, M.M., McDowell, F.H., and Muenter, M.D. (1990) An examination of male-female differences in progression and mortality of Parkinson’s disease. Neurology 40, 763–766.
Ebmeier, K.P., Calder, S.A., Crawford, J.R., Stewart, L., Besson, J.A., and Mutch, W.J. (1990) Clinical features predicting dementia in idiopathic Parkinson’s disease: a follow-up study. Neurology 40, 1222–1224.
Katzman, R. (1993) Education and the prevalence of dementia and Alzheimer’s disease. Neurology 43, 13–20.
Piccirilli, M., Piccinin, G.L., and Agostini, L. (1984) Characteristic clinical aspects of Parkinson patients with intellectual impairment. Eur. Neurol. 23, 44–50.
Elizan, T.S., Sroka, H., Maker, H., Smith, H., and Yahr, M.D. (1986) Dementia in idiopathic Parkinson’s disease. Variables associated with its occurrence in 203 patients. J. Neural Transm. 65, 285–302.
Giladi, N., Treves, T.A., Paleacu, D., et al. (2000) Risk factors for dementia, depression and psychosis in longstanding Parkinson’s disease. J. Neural Transm. (Budapest) 107, 59–71.
Agid, Y., Graybiel, A.M., Ruberg, M., et al. (1990) The efficacy of levodopa treatment declines in the course of Parkinson’s disease: do nondopaminergic lesions play a role? Adv. Neurol. 53, 83–100.
Levy, G., Tang, M.X., Cote, L.J., et al. (2000) Motor impairment in PD: relationship to incident dementia and age. Neurology 55, 539–544.
Zetusky, W.J., Jankovic, J., and Pirozzolo, F.J. (1985) The heterogeneity of Parkinson’s disease: clinical and prognostic implications. Neurology 35, 522–526.
Marder, K., Tang, M., Hemenegildo, N., et al. (1993) A factor analysis of extrapyramidal signs as risk factors for dementia in Parkinson’s disease. Mov. Disord. 8, 409.
Hoehn, M.M. and Yahr, M.D. (1967) Parkinsonism: onset, progression and mortality. Neurology 17, 427–442.
Jankovic, J., McDermott, M., Carter, J., et al. (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40, 1529–1534.
Hershey, L.A., Feldman, B.J., Kim, K.Y., Commichau, C., and Lichter, D.G. (1991) Tremor at onset. Predictor of cognitive and motor outcome in Parkinson’s disease? Arch. Neurol. 48, 1049–1051.
Viitanen, M., Mortimer, J.A., and Webster, D.D. (1994) Association between presenting motor symptoms and the risk of cognitive impairment in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 57, 1203–1207.
Portin, R. and Rinne, U.K. (1987) Predictive factors for cognitive deterioration and dementia in Parkinson’s disease. Adv. Neurol. 45, 413–416.
Caparros-Lefebvre, D., Pecheux, N., Petit, V., Duhamel, A., and Petit, H. (1995) Which factors predict cognitive decline in Parkinson’s disease? J. Neurol. Neurosurg. Psychiatry 58, 51–55.
Starkstein, S.E., Mayberg, H.S., Leiguarda, R., Preziosi, T.J., and Robinson, R.G. (1992) A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 55, 377–382.
Hamilton, M. (1960) A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56–62.
Starkstein, S.E., Bolduc, P.L., Mayberg, H.S., Preziosi, T.J., and Robinson, R.G. (1990) Cognitive impairments and depression in Parkinson’s disease: a follow up study. J. Neurol. Neurosurg. Psychiatry 53, 597–602.
Montgomery, S.A. and Asberg, M. (1979) A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382–389.
Guillard, A., Chastang, C., and Fenelon, G. (1986) Etude a long terme de 416 cas de maladie de Parkinson. Facteurs de pronostic et implications therapeutiques. Revue Neurologique 142, 207–214.
Friedman, A. and Barcikowska, M. (1994) Dementia in Parkinson’s disease. Dementia 5, 12–16.
Jacobs, D.M., Marder, K., Cote, L.J., Sano, M., Stern, Y., and Mayeux, R. (1995) Neuropsychological characteristics of preclinical dementia in Parkinson’s disease. Neurology 45, 1691–1696.
Levy, G., Jacobs, D.M., Tang, M.X., et al. (2002) Memory and executive function impairment predict dementia in Parkinson’s disease. Mov. Disord., in press.
Piccirilli, M., D’Alessandro, P., Finali, G., Piccinin, G.L., and Agostini, L. (1989) Frontal lobe dysfunction in Parkinson’s disease: prognostic value for dementia? Eur. Neurol. 29, 71–76.
Piccirilli, M., D’Alessandro, P., Finali, G., and Piccinin, G. (1997) Early frontal impairment as a predictor of dementia in Parkinson’s disease. Neurology 48, 546–547.
Salganik, I, and Korczyn, A. (1990) Risk factors for dementia in Parkinson’s disease. Adv. Neurol. 53, 343–347.
Levy, G., Tang, M.X., Cote, L.J., et al. (2002) Do risk factors for Alzheimer’s disease predict dementia in Parkinson’s disease? An exploratory study. Mov. Disord. 17, 250–257.
Arai, H., Muramatsu, T., Higuchi, S., Sasaki, H., and Trojanowski, J.Q. (1994) Apolipoprotein E gene in Parkinson’s disease with or without dementia. Lancet 344, 889.
Marder, K., Maestre, G., Cote, L., et al. (1994) The apolipoprotein epsilon 4 allele in Parkinson’s disease with and without dementia. Neurology 44, 1330–1331.
Koller, W.C., Glatt, S.L., Hubble, J.P., et al. (1995) Apolipoprotein E genotypes in Parkinson’s disease with and without dementia. Ann. Neurol 37, 242–245.
Inzelberg, R., Chapman, J., Treves, T.A., et al. (1998) Apolipoprotein E4 in Parkinson disease and dementia: new data and meta-analysis of published studies. Alzheimer Dis. Assoc. Disord. 12, 45–48.
Whitehead, A.S., Bertrandy, S., Finnan, F., Butler, A., Smith, G.D., and Ben Shlomo, Y. (1996) Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 61, 347–351.
Harhangi, B.S., de Rijk, M.C., van Duijn, C.M., Van Broeckhoven, C., Hofman, A., and Breteler, M.M. (2000) APOE and the risk of PD with or without dementia in a population-based study. Neurology 54, 1272–1276.
Egensperger, R., Bancher, C., Kosel, S., Jellinger, K., Mehraein, P., and Graeber, M.B. (1996) The apolipoprotein E epsilon 4 allele in Parkinson’s disease with Alzheimer lesions. Biochem. Biophys. Res. Commun. 224, 484–486.
Mattila, P.M., Koskela, T., Roytta, M., et al. (1998) Apolipoprotein E epsilon4 allele frequency is increased in Parkinson’s disease only with co-existing Alzheimer pathology. Acta Neuropathol. 96, 417–420.
Mattila, K.M., Rinne, J.O., Roytta, M., et al. (2000) Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer’s disease and in Parkinson’s disease with coexisting Alzheimer pathology. J. Med. Genet. 37, 766–770.
Wilhelmsen, K., Mirel, D., Marder, K., et al. (1997) Is there a genetic susceptibility locus for Parkinson’s disease on chromosome 22q13? Ann. Neurol. 41, 813–817.
Hubble, J.P., Kurth, J.H., Glatt, S.L., et al. (1998) Gene-toxin interaction as a putative risk factor for Parkinson’s disease with dementia. Neuroepidemiology 17, 96–104.
Heston, L.L. (1980) Dementia associated with Parkinson’s disease: a genetic study. J. Neurol. Neurosurg. Psychiatry 43, 846–848.
Marder, K., Tang, M.X., Alfaro, B., et al. (1999) Risk of Alzheimer’s disease in relatives of Parkinson’s disease patients with and without dementia. Neurology 52, 719–724.
Mickel, S.F., Broste, S.K., and Hiner, B.C. (1997) Lack of overlap in genetic risks for Alzheimer’s disease and Parkinson’s disease. Neurology 48, 942–949.
Marder, K., Tang, M.X., Alfaro, B., et al. (1998) Postmenopausal estrogen use and Parkinson’s disease with and without dementia. Neurology 50, 1141–1143.
Hughes, A.J., Daniel, S.E., Blankson, S., and Lees, A.J. (1993) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch. Neurol. 50, 140–148.
Mattila, P.M., Rinne, J.O., Helenius, H., Dickson, D.W., and Roytta, M. (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease. Acta Neuropathol. 100, 285–290.
Hurtig, H. I., Trojanowski, J.Q., Galvin, J., et al. (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease. Neurology 54, 1916–1921.
Jellinger, K. (2000) Morphological substrates of mental dysfunction in Lewy body disease: an update, in Advances in Dementia Research (Jellinger, K., Schmidt, R., and Windisch, M., eds.), Springer-Verlag, New York, pp. 185–212.
Loranger, A.W., Goodell, H., McDowell, F.H., Lee, J.E., and Sweet, R.D. (1972) Intellectual impairment in Parkinson’s syndrome. Brain 95, 405–412.
Lieberman, A., Dziatolowski, M., Kupersmith, M., et al. (1979) Dementia in Parkinson disease. Ann. Neurol. 6, 355–359.
Huber, S.J. and Paulson, G.W. (1986) Relationship between primitive reflexes and severity in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 49, 1298–1300.
Pillon, B., Dubois, B., Ploska, A., and Agid, Y. (1991) Severity and specificity of cognitive impairment in Alzheimer’s, Huntington’s, and Parkinson’s diseases and progressive supranuclear palsy. Neurology 41, 634–643.
Mjones, H. (1949) Paralysis agitans. A clinical and genetic study. Acta Psychiat. Neurol. 54(Suppl.), 1–195.
Ebmeier, K.P., Calder, S.A., Crawford, J.R., Stewart, L., Cochrane, R.H., and Besson, J.A. (1991) Dementia in idiopathic Parkinson’s disease: prevalence and relationship with symptoms and signs of parkinsonism. Psychol. Med. 21, 69–76.
Tison, F., Dartigues, J.F., Auriacombe, S., Letenneur, L., Boller, F., and Alperovitch, A. (1995) Dementia in Parkinson’s disease: a population-based study in ambulatory and institutionalized individuals. Neurology 45, 705–708.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Levy, G., Marder, K. (2003). Prevalence, Incidence, and Risk Factors for Dementia in Parkinson’s Disease. In: Bédard, MA., Agid, Y., Chouinard, S., Fahn, S., Korczyn, A.D., Lespérance, P. (eds) Mental and Behavioral Dysfunction in Movement Disorders. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-326-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-59259-326-2_20
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-372-5
Online ISBN: 978-1-59259-326-2
eBook Packages: Springer Book Archive